Liquidia Co. (NASDAQ:LQDA) General Counsel Sells $80,931.48 in Stock

Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler sold 5,964 shares of the business’s stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $80,931.48. Following the transaction, the general counsel now owns 570,301 shares of the company’s stock, valued at $7,738,984.57. This trade represents a 1.03 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Liquidia Trading Up 0.3 %

Liquidia stock opened at $13.72 on Friday. The stock has a 50 day moving average of $14.70 and a two-hundred day moving average of $12.76. Liquidia Co. has a twelve month low of $8.26 and a twelve month high of $16.81. The stock has a market capitalization of $1.17 billion, a price-to-earnings ratio of -8.42 and a beta of 0.23.

Liquidia (NASDAQ:LQDA) last issued its quarterly earnings results on Wednesday, March 19th. The company reported ($0.46) earnings per share for the quarter, missing the consensus estimate of ($0.38) by ($0.08). The company had revenue of $2.92 million for the quarter, compared to analyst estimates of $4.60 million. Liquidia had a negative return on equity of 163.21% and a negative net margin of 765.38%. Equities analysts predict that Liquidia Co. will post -1.51 earnings per share for the current year.

Institutional Trading of Liquidia

Several hedge funds and other institutional investors have recently made changes to their positions in LQDA. LM Advisors LLC acquired a new stake in Liquidia in the fourth quarter valued at about $25,948,000. Invesco Ltd. lifted its holdings in shares of Liquidia by 2,675.0% in the 4th quarter. Invesco Ltd. now owns 700,171 shares of the company’s stock valued at $8,234,000 after buying an additional 674,940 shares during the period. Janus Henderson Group PLC boosted its stake in shares of Liquidia by 1,484.5% in the fourth quarter. Janus Henderson Group PLC now owns 535,552 shares of the company’s stock valued at $6,293,000 after buying an additional 501,752 shares in the last quarter. Mirabella Financial Services LLP acquired a new position in Liquidia during the fourth quarter worth $5,880,000. Finally, Eversept Partners LP raised its position in Liquidia by 314.1% in the fourth quarter. Eversept Partners LP now owns 571,305 shares of the company’s stock worth $6,719,000 after acquiring an additional 433,356 shares in the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on LQDA. Needham & Company LLC reiterated a “buy” rating and issued a $25.00 price target on shares of Liquidia in a research note on Thursday, April 10th. Scotiabank restated an “outperform” rating on shares of Liquidia in a research note on Thursday, March 20th. HC Wainwright reissued a “buy” rating and issued a $29.00 target price on shares of Liquidia in a report on Thursday, March 20th. Finally, Wells Fargo & Company started coverage on Liquidia in a research note on Friday, December 20th. They set an “overweight” rating and a $20.00 price target on the stock. One research analyst has rated the stock with a hold rating, six have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $26.63.

Liquidia Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).